Skip to main content
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
129.64
-3.80 (-2.85%)
At close: Mar 5, 2026, 4:00 PM EST
129.65
+0.01 (0.01%)
Pre-market: Mar 6, 2026, 4:40 AM EST

Neurocrine Biosciences Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Ingrezza
2.51B 2.47B 2.40B 2.35B 2.31B 2.20B 2.07B 1.93B - -
Ingrezza Growth
8.66% 12.40% 15.74% 21.80% 26.00% 26.72% 27.42% 25.79% - -
Collaboration and Other
26.60M 25.90M 26.40M 27.30M 24.70M 26.20M 27.70M 27.70M
Collaboration and Other Growth
7.69% -1.15% -4.69% -1.44% -6.79% 1.16% 0.73% -41.44%
Ongentys and Other Products
19.10M 19.80M 18.30M 18.20M 17.20M 18.00M 20.40M 22.70M - - -
Ongentys and Other Products Growth
11.05% 10.00% -10.29% -19.82% -30.08% -21.74% 3.03% 45.51% - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.